Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
This page offers a collection of 17 insightful articles on investing, covering strategies, market trends, and expert tips to enhance your financial journey.
15,957 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
As tech’s power demand surges, data centers are becoming a bigger profit driver for utilities, prompting fresh debate...
Hedge fund veteran Dan Loeb argues tech is the most attractive sector in the current rally, warning against draconian...
A major asset sale could recalibrate FMC’s balance sheet and growth trajectory. This guide breaks down what the deal ...
Nebius stock skyrocketed more, driven by demand for AI infrastructure. This guide breaks down the drivers, the number...
As AI expands from novelty to durable demand, investors wonder if the AI trade is entering its second wave. This arti...
SpaceX's planned NASDAQ debut includes two pivotal admissions that could influence investor risk assessments: Starshi...
Schwab’s US Large-Cap ETF (SCHX) remains a cost-efficient way to diversify across the core U.S. market. As volatility...
A wave of AI demand and energy-cost pressures are reviving interest in crypto operators who pivot to AI compute. The ...
SoFi CEO Anthony Noto quietly bought the dip in SOFI stock across four trades this spring. This article breaks down t...
Broadcom is edging toward a 52-week peak as AI demand fuels revenue growth and capital returns. Analysts weigh buy, h...
A memory-focused rally has vaulted a mid-cap equipment maker by about 90% in 2.5 months, shifting attention away from...